Sinanoğlu, OrhunEkici, SinanBalci, M. B. CanHazar, A. IsmetNuhoğlu, Baris2024-07-122024-07-1220142287-88822287-903X10.12954/PI.14043https://doi.org/10.12954/PI.14043https://hdl.handle.net/20.500.12415/6759Purpose: To compare urethral stricture rates in comorbid patients undergoing plasmakinetic transurethral resection of the prostate (PK-TURP) and monopolar transurethral resection of the prostate (M-TURP) for benign prostatic hyperplasia. Methods: The data of 317 patients with comorbidities undergoing either PK-TURP or M-TURP from September 2008 to December 2012 were retrospectively evaluated. Preoperative and postoperative 12-month International Prostate Symptom Score, maximal flow rate, postoperative International Index of Erectile Function scores, and urethral stricture rates were evaluated. Results: A total of 154 patients underwent M-TURP and 163 patients underwent PK-TURP. Urethral stricture rates were 6/154 in the M-TURP treatment arm and 17/163 in the PK-TURP treatment arm (P= 0.000). In the presence of hypertension and/or coronary artery disease and/or diabetes mellitus, the risk of urethral stricture complication was significantly higher in the PK-TURP group than in the M-TURP group (P= 0.000). Conclusions: The risk of urethral stricture increases with PK-TURP in elderly patients with a large prostate and concomitant hypertension and/or coronary artery disease and/or diabetes mellitus. Therefore, PK-TURP should be performed cautiously in this group of benign prostatic hyperplasia patients.eninfo:eu-repo/semantics/openAccessProstatic HyperplasiaComorbidityTransurethral Resection Of ProstateUrethral StrictureArticle1263253250231212WOS:000216583200003N/A